Cargando…

Mizoribine: A New Approach in the Treatment of Renal Disease

Mizoribine (MZB) is an imidazole nucleoside and an immunosuppressive agent. The immunosuppressive effect of MZB has been reported to be due to the inhibition of DNA synthesis in the S phase of the cell cycle. Because of its relative lack of toxicity, during the past decade MZB has been frequently us...

Descripción completa

Detalles Bibliográficos
Autor principal:	Kawasaki, Yukihiko
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2009
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2801010/ https://www.ncbi.nlm.nih.gov/pubmed/20052390 http://dx.doi.org/10.1155/2009/681482

Ejemplares similares

Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome
por: Saito, Takao, et al.
Publicado: (2016)

Involvement of Multiple Transporters-mediated Transports in Mizoribine and Methotrexate Pharmacokinetics
por: Murakami, Teruo, et al.
Publicado: (2012)

Mizoribine treatment in an elderly diabetic patient with antisynthetase-associated interstitial lung disease
por: Nagai, Kei, et al.
Publicado: (2020)

The Efficacy and Safety of Mizoribine versus Mycophenolate Mofetil for the Treatment of Renal Transplantation: A Systematic Review and Meta-Analysis
por: Chen, Jie, et al.
Publicado: (2022)

Fanconi syndrome in an elderly patient with membranous nephropathy during treatment with the immunosuppressant mizoribine
por: Nishikawa, Sho, et al.
Publicado: (2022)

Mizoribine Ameliorates Renal Injury and Hypertension along with the Attenuation of Renal Caspase-1 Expression in Aldosterone-Salt-Treated Rats
por: Doi, Toshiki, et al.
Publicado: (2014)

In Vitro and in Vivo Antiviral Activity of Mizoribine Against Foot-And-Mouth Disease Virus
por: Li, Shi-Fang, et al.
Publicado: (2019)

Evaluation of Mizoribine as an Immunosuppressant in Subrenal Capsule Assay Using Immunocompetent Mice
por: Chen, Dong‐Yi, et al.
Publicado: (1990)

The Immunosuppressive Agent Mizoribine Monophosphate Is an Inhibitor of the Human RNA Capping Enzyme
por: Picard-Jean, Frédéric, et al.
Publicado: (2013)

Comparison of Treatment Effect and Tolerance of the Topical Application of Mizoribine and Cyclosporine A in a Mouse Dry Eye Model
por: Lin, Xiang, et al.
Publicado: (2020)

Efficacy and safety of adding mizoribine to standard treatment in patients with immunoglobulin A nephropathy: A randomized controlled trial
por: Hirai, Keiji, et al.
Publicado: (2017)

Nitazoxanide protects cats from feline calicivirus infection and acts synergistically with mizoribine in vitro
por: Cui, Zhanding, et al.
Publicado: (2020)

Influence of cyclosporine A on glomerular growth and the effect of mizoribine and losartan on cyclosporine nephrotoxicity in young rats
por: Kim, Ji Hong, et al.
Publicado: (2016)

Mizoribine provides effective treatment of sequential histological change of arteritis and reduction of inflammatory cytokines and chemokines in an animal model of Kawasaki disease
por: Takahashi, Kei, et al.
Publicado: (2011)

Inhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirus
por: Saijo, Masayuki, et al.
Publicado: (2005)

Methylprednisolone pulse therapy combined with mizoribine following tonsillectomy for immunoglobulin A nephropathy: clinical remission rate, steroid sparing effect, and maintenance of renal function
por: Kaneko, Tomohiro, et al.
Publicado: (2010)

Successful Treatment of Adult IgA Nephropathy with Nephrotic-Level Proteinuria by Combination Therapy Including Long-Term Coadministration of Mizoribine
por: Okonogi, Hideo, et al.
Publicado: (2012)

Efficacy and Safety of Mizoribine for the Treatment of Refractory Nephrotic Syndrome: Protocol for a Multicenter, Controlled, Open-label, Randomized Controlled Trial
por: Dong, Zheyi, et al.
Publicado: (2023)

Efficacy of mizoribine pulse therapy in patients with rheumatoid arthritis who show a reduced or insufficient response to infliximab
por: Horikoshi, Masanobu, et al.
Publicado: (2009)

The Efficacy of Mizoribine (Inosine Monophosphate Dehydrogenase Inhibitor) for ANCA-Associated Vasculitis with Hepatitis B Virus Carrier
por: Muratsu, Jun, et al.
Publicado: (2012)

Long-term post-marketing surveillance of mizoribine for the treatment of lupus nephritis: Safety and efficacy during a 3-year follow-up
por: Yagi, Nobuyuki, et al.
Publicado: (2014)

Comparative efficacy and safety of mizoribine and mycophenolate mofetil for treating systemic lupus erythematosus: a retrospective cohort study
por: Ayano, Masahiro, et al.
Publicado: (2022)

A four-drug combination therapy consisting of low-dose tacrolimus, low-dose mycophenolate mofetil, corticosteroids, and mizoribine in living donor renal transplantation: A randomized study
por: Yan, Tian-zhong, et al.
Publicado: (2016)

Mizoribine Synchronized Methotrexate Therapy should be Considered when Treating Rheumatoid Arthritis Patients with an Inadequate Response to Various Combination Therapies
por: Ikeda, Keigo, et al.
Publicado: (2017)

Mizoribine as a safe and effective combined maintenance therapy with prednisolone for anti-neutrophil cytoplasmic antibody-associated vasculitis in a hemodialysis patient
por: Nakamura, Gen, et al.
Publicado: (2013)

Comparison of immunosuppressive therapies for IgA nephropathy after tonsillectomy: three-course versus one-course steroid pulse combined with mizoribine
por: Kaneko, Tomohiro, et al.
Publicado: (2015)

IgG4-Related Tubulointerstitial Nephritis Associated with Membranous Nephropathy in Two Patients: Remission after Administering a Combination of Steroid and Mizoribine
por: Miyata, Kana N., et al.
Publicado: (2014)

Everolimus – a new approach in the treatment of renal cell carcinoma
por: Anandappa, G, et al.
Publicado: (2010)

Conversion from mycophenolate mofetil to mizoribine in the early stages of BK polyomavirus infection could improve kidney allograft prognosis: a single-center study from China
por: Li, Ping, et al.
Publicado: (2021)

Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial)
por: Hama, Taketsugu, et al.
Publicado: (2018)

New approaches to first-line treatment of advanced renal cell carcinoma
por: George, Daniel J., et al.
Publicado: (2021)

Immunotherapy and Metastatic Renal Cell Carcinoma: A Review of New Treatment Approaches
por: Kathuria-Prakash, Nikhita, et al.
Publicado: (2021)

Personalized Medicine: New Perspectives for the Diagnosis and the Treatment of Renal Diseases
por: Gluba-Brzózka, Anna, et al.
Publicado: (2017)

Update and new approaches in the treatment of Castleman disease
por: Chan, Kah-Lok, et al.
Publicado: (2016)

New Approaches to the Prevention and Treatment of Viral Diseases
por: Pronin, Alexander V., et al.
Publicado: (2021)

New approaches to symptomatic treatments for Alzheimer’s disease
por: Cummings, Jeffrey
Publicado: (2021)

CARs: a new approach for the treatment of autoimmune diseases
por: Sun, Yeting, et al.
Publicado: (2022)

A case of anti-neutrophil cytoplasmic antibody-associated vasculitis with anti-glomerular basement membrane antibodies that was successfully treated with mizoribine as a safe and effective remission maintenance therapy with prednisolone and plasma exchange
por: Ikeda, Yuki, et al.
Publicado: (2019)

Differences in response to treatment in children with severe IgA nephropathy according to patient age
por: Kawasaki, Yukihiko, et al.
Publicado: (2023)

New Evidence-Based Treatment Approach in Behçet's Disease
por: Alpsoy, Erkan
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_sbg790ep52bd30216a2b8lucml